An oral bacterial lysate for the prevention of recurrent infections of the respiratory tract. Results of a double-blind placebo controlled 6 months study in 342 patients

1990 ◽  
pp. 351-352
Author(s):  
H Fischer ◽  
H-P Eckenberger ◽  
A van Aubel
Keyword(s):  
Respiratory Tract ◽  
Recurrent Infections ◽  
Bacterial Lysate ◽  
Double Blind ◽  
Double Blind Placebo

A Placebo Controlled, Double-Blind Evaluation of Levamisole in the Reduction of the Frequency, Duration and Severity of Attacks in Children Suffering from Recurrent Upper Respiratory Tract Infections

1979 ◽  
Vol 7 (4) ◽  
pp. 302-304 ◽  
Author(s):  
F Dils
Keyword(s):  
Respiratory Tract ◽  
Respiratory Tract Infections ◽  
Controlled Study ◽  
Upper Respiratory Tract ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Single Body ◽  
Upper Respiratory ◽  
Tract Infections ◽  
Adjusted Dose

In a double-blind placebo controlled study of levamisole in the treatment of children with recurrent upper respiratory tract infection (URI) eighty-six patients took part. Medication was given once a week, in a single body-weight adjusted dose. The children treated with levamisole had a statistically significantly reduced incidence of episodes of infection which were less severe, less prolonged and required less antibiotics. No side-effects were reported.

Sign in / Sign up

Export Citation Format

Share Document